• レポートコード:MRC2-11QY11545 • 出版社/出版日:QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、94ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は皮膚肥満細胞症のグローバル市場について調査・分析したレポートです。種類別(抗ヒスタミン剤、コルチコステロイド、プロトンポンプ阻害剤、免疫調節剤、肥満細胞安定剤)市場規模、用途別(病院、外来手術センター、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚肥満細胞症の競争状況、市場シェア ・世界の皮膚肥満細胞症市場:種類別市場規模 2015年-2020年(抗ヒスタミン剤、コルチコステロイド、プロトンポンプ阻害剤、免疫調節剤、肥満細胞安定剤) ・世界の皮膚肥満細胞症市場:種類別市場規模予測 2021年-2026年(抗ヒスタミン剤、コルチコステロイド、プロトンポンプ阻害剤、免疫調節剤、肥満細胞安定剤) ・世界の皮膚肥満細胞症市場:用途別市場規模 2015年-2020年(病院、外来手術センター、その他) ・世界の皮膚肥満細胞症市場:用途別市場規模予測 2021年-2026年(病院、外来手術センター、その他) ・北米の皮膚肥満細胞症市場分析:米国、カナダ ・ヨーロッパの皮膚肥満細胞症市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚肥満細胞症市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚肥満細胞症市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚肥満細胞症市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):AB Science、Novartis、BioCentury、Rarediseases ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mastocytosis is rare condition characterized by excessive accumulation of mast cells in the body tissues. Mast cells release large amounts of histamine in blood which leads to itchy skin, skin rash and hot flushes. These cells are found in skin and the lining of stomach and lungs. Mast cells accumulated in the skin is referred to as cutaneous mastocytosis. Usually affecting children, the most common symptoms of cutaneous mastocytosis is abnormal growth on the skin such as spots or blisters which can form a rash on the body. The World Health Organization (WHO) has classified cutaneous mastocytosis into three variants namely urticaria pigmentosa, diffuse cutaneous mastocytosis and solitary cutaneous mastocytosis. Besides these, there are two other forms of cutaneous mastocytosis namely nodular mastocytosis and telangiectasia macularis eruptive perstans (TMEP) which are currently under review as they are very rare form of condition.
Treatment for cutaneous mastocytosis mainly aims to relieve symptoms. Therefore, medications such as antihistamines, corticosteroids, proton pump inhibitors, immunomodulators and mast cell stabilizers. Cromolyn sodium oral solution is the only FDA approved medication for the treatment of mastocytosis. However, these products are often associated with undesired side effects including hypo pigmentation, acne, skin thinning and secondary infection. With limited evidence to support their long term safety, there is a huge opportunity for novel and effective therapies.
Market Analysis and Insights: Global Cutaneous Mastocytosis Market
The global Cutaneous Mastocytosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cutaneous Mastocytosis Scope and Market Size
Cutaneous Mastocytosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cutaneous Mastocytosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AB Science
Novartis
BioCentury
Rarediseases
…
Market segment by Type, the product can be split into
Antihistamines
Corticosteroids
Proton Pump Inhibitors
Immunomodulators
Mast Cell Stabilizers
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cutaneous Mastocytosis Revenue
1.4 Market by Type
1.4.1 Global Cutaneous Mastocytosis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antihistamines
1.4.3 Corticosteroids
1.4.4 Proton Pump Inhibitors
1.4.5 Immunomodulators
1.4.6 Mast Cell Stabilizers
1.5 Market by Application
1.5.1 Global Cutaneous Mastocytosis Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cutaneous Mastocytosis Market Perspective (2015-2026)
2.2 Global Cutaneous Mastocytosis Growth Trends by Regions
2.2.1 Cutaneous Mastocytosis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cutaneous Mastocytosis Historic Market Share by Regions (2015-2020)
2.2.3 Cutaneous Mastocytosis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cutaneous Mastocytosis Market Growth Strategy
2.3.6 Primary Interviews with Key Cutaneous Mastocytosis Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cutaneous Mastocytosis Players by Market Size
3.1.1 Global Top Cutaneous Mastocytosis Players by Revenue (2015-2020)
3.1.2 Global Cutaneous Mastocytosis Revenue Market Share by Players (2015-2020)
3.1.3 Global Cutaneous Mastocytosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cutaneous Mastocytosis Market Concentration Ratio
3.2.1 Global Cutaneous Mastocytosis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cutaneous Mastocytosis Revenue in 2019
3.3 Cutaneous Mastocytosis Key Players Head office and Area Served
3.4 Key Players Cutaneous Mastocytosis Product Solution and Service
3.5 Date of Enter into Cutaneous Mastocytosis Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cutaneous Mastocytosis Historic Market Size by Type (2015-2020)
4.2 Global Cutaneous Mastocytosis Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cutaneous Mastocytosis Market Size by Application (2015-2020)
5.2 Global Cutaneous Mastocytosis Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cutaneous Mastocytosis Market Size (2015-2020)
6.2 Cutaneous Mastocytosis Key Players in North America (2019-2020)
6.3 North America Cutaneous Mastocytosis Market Size by Type (2015-2020)
6.4 North America Cutaneous Mastocytosis Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cutaneous Mastocytosis Market Size (2015-2020)
7.2 Cutaneous Mastocytosis Key Players in Europe (2019-2020)
7.3 Europe Cutaneous Mastocytosis Market Size by Type (2015-2020)
7.4 Europe Cutaneous Mastocytosis Market Size by Application (2015-2020)
8 China
8.1 China Cutaneous Mastocytosis Market Size (2015-2020)
8.2 Cutaneous Mastocytosis Key Players in China (2019-2020)
8.3 China Cutaneous Mastocytosis Market Size by Type (2015-2020)
8.4 China Cutaneous Mastocytosis Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cutaneous Mastocytosis Market Size (2015-2020)
9.2 Cutaneous Mastocytosis Key Players in Japan (2019-2020)
9.3 Japan Cutaneous Mastocytosis Market Size by Type (2015-2020)
9.4 Japan Cutaneous Mastocytosis Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cutaneous Mastocytosis Market Size (2015-2020)
10.2 Cutaneous Mastocytosis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cutaneous Mastocytosis Market Size by Type (2015-2020)
10.4 Southeast Asia Cutaneous Mastocytosis Market Size by Application (2015-2020)
11 India
11.1 India Cutaneous Mastocytosis Market Size (2015-2020)
11.2 Cutaneous Mastocytosis Key Players in India (2019-2020)
11.3 India Cutaneous Mastocytosis Market Size by Type (2015-2020)
11.4 India Cutaneous Mastocytosis Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cutaneous Mastocytosis Market Size (2015-2020)
12.2 Cutaneous Mastocytosis Key Players in Central & South America (2019-2020)
12.3 Central & South America Cutaneous Mastocytosis Market Size by Type (2015-2020)
12.4 Central & South America Cutaneous Mastocytosis Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AB Science
13.1.1 AB Science Company Details
13.1.2 AB Science Business Overview
13.1.3 AB Science Cutaneous Mastocytosis Introduction
13.1.4 AB Science Revenue in Cutaneous Mastocytosis Business (2015-2020))
13.1.5 AB Science Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Cutaneous Mastocytosis Introduction
13.2.4 Novartis Revenue in Cutaneous Mastocytosis Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 BioCentury
13.3.1 BioCentury Company Details
13.3.2 BioCentury Business Overview
13.3.3 BioCentury Cutaneous Mastocytosis Introduction
13.3.4 BioCentury Revenue in Cutaneous Mastocytosis Business (2015-2020)
13.3.5 BioCentury Recent Development
13.4 Rarediseases
13.4.1 Rarediseases Company Details
13.4.2 Rarediseases Business Overview
13.4.3 Rarediseases Cutaneous Mastocytosis Introduction
13.4.4 Rarediseases Revenue in Cutaneous Mastocytosis Business (2015-2020)
13.4.5 Rarediseases Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cutaneous Mastocytosis Key Market Segments
Table 2. Key Players Covered: Ranking by Cutaneous Mastocytosis Revenue
Table 3. Ranking of Global Top Cutaneous Mastocytosis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cutaneous Mastocytosis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Antihistamines
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Proton Pump Inhibitors
Table 8. Key Players of Immunomodulators
Table 9. Key Players of Mast Cell Stabilizers
Table 10. Global Cutaneous Mastocytosis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cutaneous Mastocytosis Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cutaneous Mastocytosis Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cutaneous Mastocytosis Market Share by Regions (2015-2020)
Table 14. Global Cutaneous Mastocytosis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cutaneous Mastocytosis Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cutaneous Mastocytosis Market Growth Strategy
Table 20. Main Points Interviewed from Key Cutaneous Mastocytosis Players
Table 21. Global Cutaneous Mastocytosis Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cutaneous Mastocytosis Market Share by Players (2015-2020)
Table 23. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis as of 2019)
Table 24. Global Cutaneous Mastocytosis by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cutaneous Mastocytosis Product Solution and Service
Table 27. Date of Enter into Cutaneous Mastocytosis Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cutaneous Mastocytosis Market Size Share by Type (2015-2020)
Table 31. Global Cutaneous Mastocytosis Revenue Market Share by Type (2021-2026)
Table 32. Global Cutaneous Mastocytosis Market Size Share by Application (2015-2020)
Table 33. Global Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cutaneous Mastocytosis Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 37. North America Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 39. North America Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 41. Europe Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 43. Europe Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 45. Europe Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 47. China Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 49. China Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 50. China Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 51. China Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 52. China Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 53. Japan Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 55. Japan Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 57. Japan Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 61. Southeast Asia Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 63. Southeast Asia Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 65. India Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 67. India Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 68. India Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 69. India Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 70. India Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cutaneous Mastocytosis Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cutaneous Mastocytosis Market Share (2019-2020)
Table 73. Central & South America Cutaneous Mastocytosis Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cutaneous Mastocytosis Market Share by Type (2015-2020)
Table 75. Central & South America Cutaneous Mastocytosis Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cutaneous Mastocytosis Market Share by Application (2015-2020)
Table 77. AB Science Company Details
Table 78. AB Science Business Overview
Table 79. AB Science Product
Table 80. AB Science Revenue in Cutaneous Mastocytosis Business (2015-2020) (Million US$)
Table 81. AB Science Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Cutaneous Mastocytosis Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. BioCentury Company Details
Table 88. BioCentury Business Overview
Table 89. BioCentury Product
Table 90. BioCentury Revenue in Cutaneous Mastocytosis Business (2015-2020) (Million US$)
Table 91. BioCentury Recent Development
Table 92. Rarediseases Company Details
Table 93. Rarediseases Business Overview
Table 94. Rarediseases Product
Table 95. Rarediseases Revenue in Cutaneous Mastocytosis Business (2015-2020) (Million US$)
Table 96. Rarediseases Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cutaneous Mastocytosis Market Share by Type: 2020 VS 2026
Figure 2. Antihistamines Features
Figure 3. Corticosteroids Features
Figure 4. Proton Pump Inhibitors Features
Figure 5. Immunomodulators Features
Figure 6. Mast Cell Stabilizers Features
Figure 7. Global Cutaneous Mastocytosis Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Cutaneous Mastocytosis Report Years Considered
Figure 12. Global Cutaneous Mastocytosis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Cutaneous Mastocytosis Market Share by Regions: 2020 VS 2026
Figure 14. Global Cutaneous Mastocytosis Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Cutaneous Mastocytosis Market Share by Players in 2019
Figure 17. Global Top Cutaneous Mastocytosis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cutaneous Mastocytosis as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Cutaneous Mastocytosis Revenue in 2019
Figure 19. North America Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Cutaneous Mastocytosis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed